Sarcoma  >>  bortezomib  >>  Phase 1
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
bortezomib / Generic mfg.
NCT00006773: Bortezomib in Treating Patients With Recurrent Glioma

Terminated
1
42
US
bortezomib, LDP 341, MLN341, VELCADE
National Cancer Institute (NCI)
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
06/07
 
NCT00620295: Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors

Completed
1
17
US
bortezomib, Velcade, gemcitabine hydrochloride, Gemzar
Masonic Cancer Center, University of Minnesota
Breast Cancer, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Sarcoma
02/09
10/09
NCT00622674: Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

Completed
1
37
US
cetuximab, Erbitux, bortezomib, Velcade
Masonic Cancer Center, University of Minnesota
Breast Cancer, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Pancreatic Cancer, Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific
08/09
02/10
NCT00580320: Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma

Completed
1
17
US
Dacarbazine and bortezomib, bortezomib (velcade)
Virginia Commonwealth University
Melanoma, Soft Tissue Sarcoma, Parathyroid Carcinoma, Small Cell Carcinoma of the Lung, Carcinoid Tumors
10/09
11/13
NCT01132911: A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas

Completed
1
5
US
Vorinostat (SAHA), Velcade (PS-341, Bortezomib)
National Cancer Institute (NCI)
Lymphoma, Sarcoma, WilmsTumor, Neuroblastoma
04/11
04/11
NCT01016730: Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma

Completed
1
24
US
Bortezomib, [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid, LDP 341, MLN341, PS-341, PS341, Velcade, Laboratory Biomarker Analysis, Questionnaire Administration
National Cancer Institute (NCI)
AIDS-Related Kaposi Sarcoma, HIV Infection, Recurrent Kaposi Sarcoma
01/15
01/15
NCT03056599: Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma

Completed
1
23
US
Multiple drug microinjection, Doxorubicin, Docetaxel, Gemcitabine, Interferon gamma, Pembrolizumab, Ipilimumab, Interferon alfa-2B, Bortezomib, Aldesleukin, Trabectedin, Eribulin, Olaratumab, Atezolizumab, Durvalumab, Avelumab, Nivolumab, Larotrectinib, Entrectinib, Avapritinib, Saline, CIVO device
Presage Biosciences, Fred Hutchinson Cancer Center, University of Washington, Northwell Health, Oregon Health and Science University
Soft Tissue Sarcoma Adult
07/21
09/21

Download Options